NatInLab, is an ambitious biopharmaceutical company with cutting-edge technology capable of creating the next generation of protease inhibitors therapeutics. Our interdisciplinary research programs focus on the discovery of the natural regulation system and the creation of novel medicines to treat devastating diseases (viral infections, neurodegenerative diseases, and oncology).
We DO claim that the etiological factor is not an enzyme (protease) itself but a lack of its regulators.
We DO research the particular proteolysis pathway and DO discover its natural regulators.
As a result of our research, we DO formulate/obtain medicines that support and stimulate the regulation of the proteolytic pathways and maintain the homeostasis in the cell.
We DO minimize/eliminate the side effects of our drugs.
Our products ARE predictable.